GLP-1s Are Not the End of Bariatric Surgery; They’re the Beginning of Better Obesity Care - Top-Institutions - MDSpire

GLP-1s Are Not the End of Bariatric Surgery; They’re the Beginning of Better Obesity Care

The premise that GLP-1 receptor agonists are replacing bariatric surgery for weight management is not just oversimplified; it’s wrong.

  • By

  • April 30, 2026

  • 6 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, Ohio

    Key Differentiators

    • Obesity Medicine

  • #2

    Keck Medicine of USC
    Keck Medicine of USC

    Los Angeles, California

    Key Differentiators

    • Obesity Medicine

  • #3

    USC Surgery
    USC Surgery

    Los Angeles, California

    Key Differentiators

    • Obesity Medicine

  • #4

    USC Digestive Health Institute
    USC Digestive Health Institute

    Los Angeles, California

    Key Differentiators

    • Obesity Medicine

  • #5

    Yale University
    Yale University

    New Haven, Connecticut

    Key Differentiators

    • Obesity Medicine

Original Source(s)

GLP-1s Are Not the End of Bariatric Surgery; They’re the Beginning of Better Obesity Care

  • by

  • April 30, 2026

Related Content

A Smarter Screen for Sleep Apnea Stimulation

A four-factor staging system stratified response rates from 90.9% to 37.5% in a retrospective cohort study, although the model showed only moderate discrimination (C statistic, 0.68) and requires external validation

Impaired Iron-Copper Metabolic Axis in Human Intestinal Mucosa After Roux-en-Y Gastric Bypass: A Prospective Transcriptomic Study Using Double-Balloon Enteroscopy

The immunometabolic nature of MASH: framing immune cells within metabolic dysfunction